GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 277 filers reported holding GW PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $130,000 | +88.4% | 600 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $69,000 | +19.0% | 600 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $58,000 | -21.6% | 600 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $74,000 | +39.6% | 600 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $53,000 | -15.9% | 600 | 0.0% | 0.00% | +50.0% |
| Q4 2019 | $63,000 | -8.7% | 600 | 0.0% | 0.00% | -33.3% |
| Q3 2019 | $69,000 | -33.0% | 600 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $103,000 | +2.0% | 600 | 0.0% | 0.00% | +33.3% |
| Q1 2019 | $101,000 | +48.5% | 600 | -14.3% | 0.00% | +50.0% |
| Q4 2018 | $68,000 | -34.6% | 700 | +16.7% | 0.00% | -33.3% |
| Q3 2018 | $104,000 | +23.8% | 600 | 0.0% | 0.00% | +50.0% |
| Q2 2018 | $84,000 | +23.5% | 600 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $68,000 | -13.9% | 600 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $79,000 | +29.5% | 600 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $61,000 | +1.7% | 600 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $60,000 | -17.8% | 600 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $73,000 | +9.0% | 600 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $67,000 | -16.2% | 600 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $80,000 | +45.5% | 600 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $55,000 | +27.9% | 600 | 0.0% | 0.00% | +100.0% |
| Q1 2016 | $43,000 | -21.8% | 600 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $55,000 | -25.7% | 600 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $74,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|